Guibin Qiao

Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 <i>EGFR</i>-Mutant Non–Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study

Wen‐Zhao Zhong, Ke‐Neng Chen, Chun Chen et al. · Journal of Clinical Oncology · 2019 · 259 citations

High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients

Guibin Qiao, Yi‐Long Wu, X-N Yang et al. · British Journal of Cancer · 2005 · 196 citations · Full text

Prognostic Biomarkers, Independent Prognostic Marker, Medicine +14

Unintrusive multi-cancer detection by circulating cell-free DNA methylation sequencing (THUNDER): development and independent validation studies

Qiang Gao, Binrong Li, G.Q. Wang et al. · Annals of Oncology · 2023 · 102 citations · Full text

Cancer Detection, Tumor Heterogeneity, Independent Validation Studies +12

Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial

Wen‐Zhao Zhong, Hong‐Hong Yan, Ke‐Neng Chen et al. · Signal Transduction and Targeted Therapy · 2023 · 74 citations · Full text

Serologic Association Between Human Papillomavirus Type 16 Infection and Esophageal Cancer in Shaanxi Province, China

Cheng Han, Guibin Qiao, N L Hubbert et al. · JNCI Journal of the National Cancer Institute · 1996 · 70 citations